Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.

导出 LinkOut

翻译打印收藏纠错

作者： Rebeca,Bailén ^[1] ; José Luis,Vicario ^[2] ; Laura,Solán ^[3] ; Irene,Sánchez-Vadillo ^[4] ; Pilar,Herrera ^[5] ; María,Calbacho ^[6] ; Raquel,Alenda ^[7] ; José Luis,López-Lorenzo ^[3] ; Karem,Humala ^[4] ; Anabelle,Chinea ^[5] ; José,Sánchez-Pina ^[6] ; Antonio,Balas ^[7] ; Miguel Ángel,Moreno ^[3] ; Javier,Arzuaga ^[3] ; Virginia,Pradillo ^[1] ; Nieves,Dorado ^[1] ; Gillen,Oarbeascoa ^[1] ; Javier,Anguita ^[2] ; José Luis,Díez-Martín ^[1] ; Mi,Kwon ^[2]

作者单位： Department of Hematology and Hemotherapy, Hospital General Universitario Gregorio Marañón, Madrid, Spain. ^[1] Translational Oncology Section, Gregorio Marañón Health Research Institute, Madrid, Spain. ^[2] Department of Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain. ^[3] Department of Hematology and Hemotherapy, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain. ^[4] Department of Hematology and Hemotherapy, Hospital Universitario La Paz, Madrid, Spain. ^[5] Department of Hematology and Hemotherapy, Hospital Universitario Ramón y Cajal, Madrid, Spain. ^[6] Department of Hematology and Hemotherapy, Hospital Universitario 12 de Octubre, Madrid, Spain. ^[7] Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain. ^[8]

关键词 Luminex ?desensitization therapy donor-specific anti HLA antibodies haplo identical hematopoietic stem cell transplantation kinetics